Dimeric Inhibin A
Inhibins are heterodimeric glycoprotein hormones secreted by the granulosa cells of the ovary in females and the Sertoli cells in the male testis. Inhibins selectively suppress the secretion of follicle stimulating hormone (FSH) from the pituitary gland and have also been shown to have local action within the gonads.
Inhibin is a 32-kdalton protein consisting of α and ΒA protein chains that are covalently joined by disulfide bonds. A bimodal increase of serum inhibin-A concentration is typically observed during normal pregnancy. Concentrations increase during the first trimester, decline after ten weeks, remain stable between 15-25 weeks of gestation, and then again increase, peaking at term. Total Inhibin A concentration is typically elevated if the fetus is affected by Down syndrome. Concentration may also be affected by gestational age, maternal weight, the number of fetuses, and preeclampsia.
Inhibin-A has also been reported to have clinical application as an adjunct to monitoring ovarian granulosa cell tumors, as well as in reproductive physiology.
The inhibin-A assay utilizes a pair of highly characterized monoclonal antibodies in a two-site immunoassay that essentially eliminates the interference of inactive free α-monomer.
- As an aid in the diagnosis and monitoring of various hormonal reproductive disorders
- As an aid during the second trimester as part of the maternal serum quad screen
- As an aid in the diagnosis of preeclamptic toxemia
- As an aid in the diagnosis of ovarian granulosa cell tumors
- Though not cleared for use, published studies suggest Inhibin-A may have clinical application as an adjunct to monitor ovarian granulosa cell tumors, as well as in reproductive physiology
Increased in:
- Pregnancy with gestational age
- Some germ cell tumors
- Down syndrome
- Ovarian granulosa cell tumors
- Preeclamptic toxemia
| Normal Cycling Females (pg/mL) | |
| Day in Cycle | pg/mL |
| Early Follicular Phase (−14 to −10) | 5.5–28.2 |
| Mid Follicular Phase (−9 to −4) | 7.9–34.5 |
| Late Follicular Phase (−3 to −1) | 19.5–102.3 |
| Mid Cycle (Day 0) | 49.9–155.5 |
| Other Reference Ranges (pg/mL) | |
| Category | pg/mL |
| IVF-Peak Levels | 354.2–1690.0 |
| PCOS-Ovulatory | 5.7–16.0 |
| Postmenopausal | 1.0–3.9 |
| Normal Males | 1.0–3.6 |
ELISA, Immunoassay.
Serum (SST).
Stability
- Ambient: 7 days
- Refrigerated: 7 days
- Frozen: 30 days
- Adv Clin Chem. 2008;45:1-29. [PMID: 18429491]
- Semin Reprod Med. 2004 Aug;22(3):195-208. [PMID: 15319822]
- J Clin Endocrinol Metab. 2007 Jul;92(7):2526-31. [PMID: 17473066]
- J Med Screen. 1998;5(3):115-9. [PMID: 9795869]
- Obstet Gynecol Clin North Am. 1997 Mar;24(1):33-47. [PMID: 9086517]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757